Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

Zacks Investment Research

24 Jun 2026, 14:50 UTC · 1h ago

Why Amneal Pharmaceuticals (AMRX) is a Top Momentum Stock for the Long-Term

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

Read original · https://www.zacks.com/stock/news/2942171/why-amneal-pharmaceuticals-amrx-is-a-top-momentum-stock-for-the-long-term?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_momentum_score-2942171

Free · No account

Track these names every morning.

Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.

We’ll watch

#equity_research#growth_investing#market_analysis#momentum_investing

Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.

Free forever · one email a day, max · unsubscribe in one click.How it works

6 related stories